CRON Earnings Date: Nov 5, 2026 (Estimated) — Cronos Group Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
Updated
When is CRON's next earnings date?
Cronos Group Inc. (CRON) is expected to report Q3 2026 earnings on Thursday, November 5, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $0.03 on revenue of $51.1M.
How did CRON do in its last earnings report?
In its most recent report on Aug 6, 2026 (Q2 2026), Cronos Group Inc. posted EPS of $0.09 versus the $0.01 estimate, a beat of 800.0%. Revenue was $53.0M against a $44.2M estimate. The stock's 1-day post-earnings move was +12.9%.
How much does CRON stock move after earnings?
CRON beat EPS estimates in 6 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 8.1% (up or down) in the day after earnings.
About Cronos Group Inc.
Cronos Group Inc. is a company primarily focused on cannabinoids. In the United States, it develops, promotes, and supplies hemp-derived wellness and beauty products under the Lord Jones and Happy Dance brands, reaching consumers through online sales, traditional retail outlets, and partnerships within the hospitality sector. Beyond hemp, the company also engages in the cultivation, production, and commercialization of cannabis and its related extracts for both therapeutic and recreational consumption. Its cannabis offerings encompass dried flower, pre-rolled joints, edibles, concentrates, and various extracts, which are distributed via wholesale channels and directly to clients. The wellness segment operates under the PEACE NATURALS platform, while its adult-use products are marketed through the Spinach brand. Additionally, Cronos exports dried cannabis and cannabis oils to international markets such as Germany, Israel, and Australia. Founded in 2012, the company's headquarters are located in Toronto, Canada.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-06 | Q2 2026 | 0.01 | 0.09 | +800.00% | $53.0M | ✅ Beat | +12.87% | +16.54% | +19.85% |
| 2026-05-11 | Q1 2026 | 0.01 | 0.04 | +300.00% | $45.2M | ✅ Beat | +8.27% | +3.54% | +9.84% |
| 2026-02-26 | Q4 2025 | 0.02 | 0.00 | -100.00% | $44.5M | ❌ Miss | -3.61% | -5.42% | -9.03% |
| 2025-11-06 | Q3 2025 | -0.02 | 0.07 | +450.00% | $36.3M | ✅ Beat | +0.82% | +3.67% | +1.63% |
| 2025-08-07 | Q2 2025 | -0.02 | -0.10 | -400.00% | $33.5M | ❌ Miss | +8.10% | +24.76% | +19.05% |
| 2025-05-08 | Q1 2025 | 0.00 | 0.02 | +100.00% | $32.3M | ✅ Beat | +8.11% | +11.35% | +7.03% |
| 2025-02-27 | Q4 2024 | -0.01 | 0.11 | +1200.00% | $30.3M | ✅ Beat | +8.11% | +9.73% | -1.08% |
| 2024-11-12 | Q3 2024 | -0.01 | 0.02 | +300.00% | $34.3M | ✅ Beat | +14.72% | +3.55% | -1.02% |
Showing last 8 quarters.
Revenue by segment & region
By segment
Q2 FY26 · $53.0M total
| Segment | Share | Revenue | YoY | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 |
|---|---|---|---|---|---|---|---|
| Cannabis Flower | 74.0% | $39.2M | +56.7% | $70.4M | $23.3M | $25.0M | $26.4M |
| Cannabis Extracts | 26.0% | $13.8M | +64.8% | $21.4M | $8.6M | $8.4M | $10.0M |
| Product and Service, Other | 0.0% | $19K | -72.9% | $499K | $310K | $70K | $13K |
By region
Q2 FY26 · $53.0M total
| Segment | Share | Revenue | YoY | Q1 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 |
|---|---|---|---|---|---|---|---|
| CANADA | 54.2% | $28.7M | +49.9% | $18.9M | $20.1M | $19.1M | $23.1M |
| ISRAEL | 28.3% | $15.0M | +60.2% | $6.4M | $9.2M | $9.4M | $11.4M |
| Other Countries | 17.5% | $9.3M | +88.3% | — | $2.9M | $4.9M | $1.9M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.